NMN and NR both boost NAD+ levels, but they differ in bioavailability, cost, and clinical evidence. Here is what the research says about choosing between them.
NAD+ (nicotinamide adenine dinucleotide) has become one of the most discussed molecules in longevity science. This coenzyme participates in hundreds of metabolic reactions, powers the sirtuins that protect our DNA, and fuels the PARP enzymes that repair it. The problem is that NAD+ levels decline roughly 50% between age 20 and 60, and this decline appears to accelerate many hallmarks of aging. Enter NMN and NR — two NAD+ precursors that have attracted enormous interest, significant investment, and a heated debate about which one actually works better.
Your body cannot simply absorb NAD+ from a supplement — the molecule is too large to enter cells directly. Instead, it must be built from precursor compounds that cross cell membranes and are then converted internally. Both NMN (nicotinamide mononucleotide) and NR (nicotinamide riboside) are biosynthetic intermediates on the pathway to NAD+. Think of them as different entry points into the same production line.
NAD+ is the fuel for several longevity-associated enzymes. Sirtuins (SIRT1-SIRT7) are NAD+-dependent deacylases that regulate gene expression, mitochondrial function, inflammation, and stress resistance. Declining NAD+ impairs sirtuin activity, which David Sinclair of Harvard Medical School has argued is a central mechanism of aging. Additionally, PARP1, the enzyme that rushes to repair DNA strand breaks, consumes enormous amounts of NAD+ — especially under conditions of oxidative stress. When NAD+ is scarce, DNA repair is compromised.
NMN is one step closer to NAD+ in the biosynthetic pathway than NR is. It is converted to NAD+ by the enzyme NMNAT (nicotinamide mononucleotide adenylyltransferase). NMN naturally occurs in small amounts in foods like edamame, broccoli, avocado, and cucumber, but food sources alone are far too low to meaningfully raise NAD+ levels.
The animal data for NMN is impressive. Studies in aging mice have shown that NMN supplementation improves energy metabolism, enhances muscle function, prevents age-related weight gain, and improves insulin sensitivity. A notable 2016 study in Cell Metabolism by Yoshino and colleagues demonstrated that NMN supplementation reversed several aspects of physiological decline in aged mice. However, the classic caveat applies: mice are not humans.